Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo

Block, 2007, Microglia-mediated neurotoxicity: uncovering the molecular mechanisms, Nat Rev Neurosci, 8, 57, 10.1038/nrn2038 Bruce-Keller, 1999, Microglial-neuronal interactions in synaptic damage and recovery, J Neurosci Res, 58, 191, 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E Chen, 2000, A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease, Nature, 408, 975, 10.1038/35046031 Cho, 2011, CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease, J Biol Chem, 286, 32713, 10.1074/jbc.M111.254268 Choi, 2011, Gami-Chunghyuldan ameliorates memory impairment and neurodegeneration induced by intrahippocampal Aβ1–42 oligomer injection, Neurobiol Learn Mem, 96, 306, 10.1016/j.nlm.2011.06.004 Chromy, 2003, Self-assembly of Abeta(1–42) into globular neurotoxins, Biochemistry, 42, 12749, 10.1021/bi030029q Cleary, 2005, Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function, Nat Neurosci, 8, 79, 10.1038/nn1372 De Simone, 2005, Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures, J Neuroinflammation, 2, 4, 10.1186/1742-2094-2-4 Dewapriya, 2013, Neoechinulin A suppresses amyloid-beta oligomer-induced microglia activation and thereby protects PC-12 cells from inflammation-mediated toxicity, Neurotoxicology, 35, 30, 10.1016/j.neuro.2012.12.004 Dinamarca, 2006, Hyperforin prevents beta-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits, Mol Psychiatr, 11, 1032, 10.1038/sj.mp.4001866 Donev, 2009, Neuronal death in Alzheimer's disease and therapeutic opportunities, J Cell Mol Med, 13, 4329, 10.1111/j.1582-4934.2009.00889.x Dong, 2009, Effects of donepezil on amyloid-beta and synapse density in the Tg2576 mouse model of Alzheimer's disease, Brain Res, 1303, 169, 10.1016/j.brainres.2009.09.097 Eikelenboom, 2006, The significance of neuroinflammation in understanding Alzheimer's disease, J Neural Transm, 113, 1685, 10.1007/s00702-006-0575-6 Giacobini, 2000, Cholinesterase inhibitors stabilize Alzheimer's disease, Ann N Y Acad Sci, 920, 321, 10.1111/j.1749-6632.2000.tb06942.x Hansen, 2008, Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis, Clin Interv Aging, 3, 211 Hashimoto, 2005, Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease, Am J Psychiatr, 162, 676, 10.1176/appi.ajp.162.4.676 Heneka, 2007, Inflammatory processes in Alzheimer's disease, J Neuroimmunol, 184, 69, 10.1016/j.jneuroim.2006.11.017 Heneka, 2010, Neuroinflammatory processes in Alzheimer's disease, J Neural Transm, 117, 919, 10.1007/s00702-010-0438-z Holmes, 2009, Systemic inflammation and disease progression in Alzheimer disease, Neurology, 73, 768, 10.1212/WNL.0b013e3181b6bb95 Hwang, 2010, Microglia signaling as a target of donepezil, Neuropharmacology, 58, 1122, 10.1016/j.neuropharm.2010.02.003 Hyman, 1984, Alzheimer's disease: cell-specific pathology isolates the hippocampal formation, Science, 225, 1168, 10.1126/science.6474172 Imbimbo, 2009, An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease, Expert Opin Investig Drugs, 18, 1147, 10.1517/13543780903066780 Jacobson, 2008, Donepezil: potential neuroprotective and disease-modifying effects, Expert Opin Drug Metab Toxicol, 4, 1363, 10.1517/17425255.4.10.1363 Jiang, 2013, The anti-inflammatory effect of donepezil on experimental autoimmune encephalomyelitis in C57 BL/6 mice, Neuropharmacology, 73, 415, 10.1016/j.neuropharm.2013.06.023 Kim, 2004, Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production, Neurobiol Aging, 25, 431, 10.1016/S0197-4580(03)00126-X Koistinaho, 2002, Role of p38 and p44/42 mitogen-activated protein kinases in microglia, Glia, 40, 175, 10.1002/glia.10151 Krishnan, 2003, Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease, Am J Psychiatr, 160, 2003, 10.1176/appi.ajp.160.11.2003 Lacor, 2007, Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease, J Neurosci, 27, 796, 10.1523/JNEUROSCI.3501-06.2007 Lawrence, 2010, The resolution of inflammation: anti-inflammatory roles for NF-kappaB, Int J Biochem Cell Biol, 42, 519, 10.1016/j.biocel.2009.12.016 McGeer, 1987, Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR, Neurosci Lett, 79, 195, 10.1016/0304-3940(87)90696-3 Meunier, 2006, The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor, Br J Pharmacol, 149, 998, 10.1038/sj.bjp.0706927 Moon, 2011, Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-beta 1–42 oligomer-injected mice, J Alzheimers Dis, 23, 147, 10.3233/JAD-2010-101263 Moon, 2012, Intracellular amyloid-beta accumulation in calcium-binding protein-deficient neurons leads to amyloid-beta plaque formation in animal model of Alzheimer's disease, J Alzheimers Dis, 29, 615, 10.3233/JAD-2011-111778 Moon, 2013, Vitamin D-binding protein interacts with Abeta and suppresses Abeta-mediated pathology, Cell Death Differ, 20, 630, 10.1038/cdd.2012.161 Narimatsu, 2009, Donepezil improves cognitive function in mice by increasing the production of insulin-like growth factor-I in the hippocampus, J Pharmacol Exp Ther, 330, 2, 10.1124/jpet.108.147280 Pan, 2009, Tripchlorolide protects neuronal cells from microglia-mediated beta-amyloid neurotoxicity through inhibiting NF-kappaB and JNK signaling, Glia, 57, 1227, 10.1002/glia.20844 Parvathy, 2009, Abeta peptide conformation determines uptake and interleukin-1alpha expression by primary microglial cells, Neurobiol Aging, 30, 1792, 10.1016/j.neurobiolaging.2008.01.011 Paxinos, 2001 Pickering, 2005, Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system, Exp Physiol, 90, 663, 10.1113/expphysiol.2005.030734 Reale, 2005, Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1 beta and interleukin-6 release from lymphocytes of Alzheimer's disease patients, Exp Gerontol, 40, 165, 10.1016/j.exger.2004.12.003 Rogers, 2000, Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study, Eur Neuropsychopharmacol, 10, 195, 10.1016/S0924-977X(00)00067-5 Rojo, 2008, Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease, Arch Med Res, 39, 1, 10.1016/j.arcmed.2007.10.001 Sakono, 2010, Amyloid oligomers: formation and toxicity of Abeta oligomers, FEBS J, 277, 1348, 10.1111/j.1742-4658.2010.07568.x Samuel, 1994, Hippocampal connectivity and Alzheimer's dementia: effects of synapse loss and tangle frequency in a two-component model, Neurology, 44, 2081, 10.1212/WNL.44.11.2081 Sarter, 1988, Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines, Psychopharmacology (Berl), 94, 491, 10.1007/BF00212843 Selkoe, 1994, Alzheimer's disease: a central role for amyloid, J Neuropathol Exp Neurol, 53, 438, 10.1097/00005072-199409000-00003 Shi, 2013, The multifunctional anti-inflammatory drugs used in the therapy of Alzheimer's disease, Curr Med Chem, 20, 2583, 10.2174/0929867311320200006 Sondag, 2009, Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia, J Neuroinflammation, 6, 1, 10.1186/1742-2094-6-1 Streit, 2002, Microglia as neuroprotective, immunocompetent cells of the CNS, Glia, 40, 133, 10.1002/glia.10154 Terry, 2011, Alzheimer's disease and age-related memory decline (preclinical), Pharmacol Biochem Behav, 99, 190, 10.1016/j.pbb.2011.02.002 Tsunekawa, 2008, Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25–35), Behav Brain Res, 190, 224, 10.1016/j.bbr.2008.03.002 Tyagi, 2010, Cholinergic protection via alpha7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation, Neurochem Int, 56, 135, 10.1016/j.neuint.2009.09.011 Tyagi, 2007, Effect of anti-dementia drugs on LPS induced neuroinflammation in mice, Life Sci, 80, 1977, 10.1016/j.lfs.2007.02.039 Wang, 2003, Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation, Nature, 421, 384, 10.1038/nature01339 Watson, 2005, Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease, Neurol Res, 27, 869, 10.1179/016164105X49436 Weninger, 2001, Inflammation and Alzheimer disease: the good, the bad, and the ugly, Nat Med, 7, 527, 10.1038/87839 White, 2005, Differential effects of oligomeric and fibrillar amyloid-beta 1–42 on astrocyte-mediated inflammation, Neurobiol Dis, 18, 459, 10.1016/j.nbd.2004.12.013 Winblad, 2006, 3-Year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy, Dement Geriatr Cogn Disord, 21, 353, 10.1159/000091790 Yoshiyama, 2010, Anti-inflammatory action of donepezil ameliorates tau pathology, synaptic loss, and neurodegeneration in a tauopathy mouse model, J Alzheimers Dis, 22, 295, 10.3233/JAD-2010-100681